Logo
x

Search

Subscribe Now

Oral

Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients with Narcolepsy

Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients...

  • October 21, 2020
Chugai Reports NDA Submission of Risdiplam to the MHLW as the First Oral Drug for SMA in Japan

Chugai Reports NDA Submission of Risdiplam to the MHLW as the First Oral Drug for SMA in Japan

  • October 16, 2020
AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program

AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program

  • September 18, 2020
Athena Bioscience's Qdolo (tramadol hydrochloride) Receives US FDA's NDA Approval for Oral Solution

Athena Bioscience's Qdolo (tramadol hydrochloride) Receives US FDA's NDA Approval for Oral Solution

  • September 1, 2020
AbbVie and Neurocrine's Oriahnn Receive the US FDA's Approval as the First Oral Therapy for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women

AbbVie and Neurocrine's Oriahnn Receive the US FDA's Approval as the First Oral Therapy for the Management of Heavy Menstrual Blee...

  • May 29, 2020
Janssen (J&J) Expands its PTG-200 Collaboration with Protagonist for Second Generation Oral IL-23 Receptor Antagonists

Janssen (J&J) Expands its PTG-200 Collaboration with Protagonist for Second Generation Oral IL-23 Receptor Antagonists

  • May 9, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.